Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1
{{output}}
Neurofibromatosis type 1 (NF1) results from germline mutations in the tumor-suppressor gene NF1 and predisposes patients to developing nervous system tumors. Twenty percent of NF1 patients harbor nonsense mutations resulting in premature termination codons (PT... ...
